SIP sigma pharmaceuticals limited

bulls run in 6 years already, page-2

  1. 6,521 Posts.
    lightbulb Created with Sketch. 284
    Breakout. Note underlying earnings is 5.9 cents PE of 20 is $1.20 approx.

    5 percent growth appears to be a low target.

    Aspen deal is over there maybe partners other generic. Also BOOTS dying for a strategic partner to launch in australia.

    API has a great franchise being priceline. The beauty sector exposure is a great part of the business.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.